Involvement of the cGMP signalling pathway in the regulation of viability in insulin-secreting BRIN-BD11 cells

FEBS Lett. 2004 Feb 13;559(1-3):118-24. doi: 10.1016/S0014-5793(04)00048-1.

Abstract

We have evaluated the hypothesis that cGMP may serve as an intracellular messenger regulating the viability of pancreatic beta-cells. A direct activator of soluble guanylyl cyclase, YC-1, caused a time- and dose-dependent loss of viability in clonal BRIN-BD11 beta-cells. This was accompanied by a rise in cGMP and was antagonised by Rp-8-pCPT-cGMPS, a selective inhibitor of protein kinase G (PKG). Reverse transcription polymerase chain reaction analysis confirmed that BRIN-BD11 cells (and human islets) express all three known isoforms of PKG (PKG-Ialpha, -Ibeta and II). Cell death induced by YC-1 was not sensitive to cell-permeable caspase inhibitors and was not accompanied by oligonucleosomal DNA fragmentation. The response was, however, inhibited by actinomycin D, suggesting that a transcription-dependent pathway of programmed cell death is involved in the actions of cGMP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cell Line
  • Cell Survival
  • Cyclic GMP / analogs & derivatives*
  • Cyclic GMP / pharmacology
  • Cyclic GMP / physiology*
  • Cyclic GMP-Dependent Protein Kinase Type I
  • Cyclic GMP-Dependent Protein Kinase Type II
  • Cyclic GMP-Dependent Protein Kinases / drug effects
  • Cyclic GMP-Dependent Protein Kinases / physiology*
  • Dactinomycin / pharmacology
  • Guanylate Cyclase / drug effects
  • Indazoles / pharmacology
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / cytology*
  • Islets of Langerhans / metabolism
  • Protein Isoforms / analysis
  • Rats
  • Signal Transduction / physiology*
  • Thionucleotides / pharmacology
  • Transcription, Genetic

Substances

  • 8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate
  • Indazoles
  • Insulin
  • Protein Isoforms
  • Thionucleotides
  • 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
  • Dactinomycin
  • Cyclic GMP-Dependent Protein Kinase Type I
  • Cyclic GMP-Dependent Protein Kinase Type II
  • Cyclic GMP-Dependent Protein Kinases
  • PRKG1 protein, human
  • PRKG2 protein, human
  • Prkg2 protein, rat
  • Guanylate Cyclase
  • Cyclic GMP